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August 2010526 AbstractsConclusions: The infraclavicular approach facilitates focused and effec-
tive treatment of patients with VTOS. It provides direct exposure to the
costoclavicular space for first rib resection and venolysis and provides versatility
for vein reconstruction, if needed.Moreover, the infraclavicular approach avoids
unnecessary exposure of the brachial plexus and sacrifice of venous collaterals,
making it an excellent approach for the treatment of VTOS.
Long-Term Impact of a Preclinical Endovascular Skills Course on
Medical Student Career Choices
Ji H. Son, MD, Mohamed A. Zayed, MD, Maureen M. Tedesco, MD,
Venita Chandra, MD, Emily A. Lilo, MD, and Jason T. Lee. Division of
Vascular Surgery, Stanford University Medical Center, Stanford, CA
Objective: Surging interest in the 05 integrated vascular surgery (VS)
residency and successful recruitment of the top students in medical school
requires early exposure to the field. We sought to determine the impact of a
high-fidelity simulation-based preclinical endovascular skills course on med-
ical student performance and ultimate career specialty choices.
Methods: Fifty-three preclinical medical students enrolled in an
8-week VS elective course from 2007-2009. Students completed a baseline
and postcourse survey and performed a renal angioplasty/stent procedure
on an endovascular simulator (pre-test). A curriculum consisting of didactic
teaching covering peripheral vascular disease andweeklymentored simulator
sessions concluded with a final graded procedure (post-test). Long-term
follow-up surveys 1 to 3 years after course completion were administered to
determine ultimate career paths.
Results: Objective and subjective performance measured on the sim-
ulator and through structured global assessment scales improved in all
students from pre-test to post-test (Fig), particularly with regard to technical
skill and overall procedural competency (P  .001). Before enrolling in the
course, 8.5% of the students expressed high interest in VS, and after
completing the course, 70% were seriously considering VS as a career option
(P  .0001). More than 95% responded that endovascular simulation
increased their knowledge and interest in VS. In long-term follow-up, 67%
were still considering VS, with other top career choices including surgical
subspecialties (76%), interventional cardiology (52%), and interventional
radiology (38%). Most respondents indicated major reasons for continued
interest in VS were the ability to practice endovascular procedures on the
simulator (81%) and mentorship from VS faculty (38%).
Conclusions: Basic endovascular skills can be efficiently introduced
through a simulation-based curriculum and leads to improved novice per-
formance. Early exposure of preclinical medical students provides an effec-
tive teaching and recruitment tool for procedural-based fields, particularly
surgical subspecialties. Mentored exposure to endovascular procedures on
the simulator positively impacts long-termmedical student attitudes towards
VS and ultimate career choices.Fig.Impact of Simulation in Physician Training During Initial Perfor-
mance of Thoracic Endovascular Aneurysm Repair (TEVAR)
Carlos E. Donayre, MD, Tyler Reynolds, MD, and Ali Khoynezhad, MD,
Surgery, Division Vascular Surgery, Harbor/UCLA, Torrance, CA, Tor-
rance, CA, and Omaha, NE
Objectives: The use of simulated environments for the interactive
education and training of physicians is being embraced. This study was
undertaken to evaluate the first use of medical simulation in TEVAR
physician training to determine its impact on initial procedure performance.
Methods: Between July 2008 and December 2009, 1211 physicians
underwent training with a Talent thoracic prosthesis before performance of
TEVAR. Group I (n 548) had only on-site in-service, group II (n 663)
completed an on-line didactic, attended a day course, which included
lectures and performance of at least 2 simulated TEVAR cases, and prosthe-
ses in-service. Complications during initial TEVAR cases were compared




Group I Group II
PNo. (%) No. (%)
Procedure mortality 39 (12) 17 (10) .55
Inaccurate delivery (58) 43 (13) 15 (9) .14
Misaligned deployment (32) 25 (8) 7 (4) .12
Positioning difficulties (40) 30 (9) 10 (6) .23
Type I endoleak (45) 36 (11) 9 (5) .03
Type III endoleak (10) 7 (2) 3 (2) .99
Kink (9) 5 (2) 4 (2) .72
Deployment complications 146 48 .0002
Rupture 10 (3) 5 (3) .99
Preoperative (15) 8 (2) 10 (6) .08
Vessel rupture (18)
Vascular bypass conversion (10) 7 (2) 3 (2) .99
Surgical conversion (4) 3 (1) 1 (1) .99
Occlusion (13) 11 (3) 2 (1) .24
Vascular complications 39 21 .91
Paralysis (14) 8 (2) 6 (3) .57
Stroke (10) 10 (3) 0 (0) .02
Neurologic complications 18 6 .38
Total complications, No. 242 92 .0001
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went simulation-assisted training prior to initial TEVAR performance had
significantly fewer total number of complications than experienced physi-
cians who did not undergo simulation training, mostly due to a significant
reduction in deployment-related complications (type I endoleaks) and
stroke incidence.
A Comparison Between Single- and Two-Stage Brachiobasilic Arterio-
venous Fistulas
Tyler S. Reynolds, MD, Mohamed Zayed, MD, Karen M. Kim, MD, Jason
T. Lee, MD, Brandon Ishaque, Ramanath B. Dukkipati, MD, Amy H. Kaji,
MD, and Christian deVirgilio, MD, General Surgery, Harbor-UCLA Med-
ical Center, Torrance, CA, and Palo Alto, CA
Objectives:Controversy exists as to whether the brachiobasilic arterio-
venous fistula (BBAVF) should be performed in one or two stages. We
compare primary failure rates, as well as primary and secondary patency rates,
of one- and two-stage BBAVF.
Methods: Patients undergoing one- and two-stage BBAVF at two
institutions were compared retrospectively with respect to age, sex, body
mass index, use of preoperative venous duplex ultrasound, diabetes, hyper-
tension, and causes of end-stage renal disease. Categoric variables were
compared using 2 and Fisher exact test. The Wilcoxon rank sum test was
used to compare continuous variables. Primary and secondary patency rates
were assessed using Kaplan-Meier survival analysis and the Cox proportional
hazards model.
Results: The study identified 90 patients (60 one-stage and 30 two-
stage). Mean follow-up was 14.2 months, and the mean time interval
between the first and second stage was 11.2 weeks. Three patients in each
group required procedures to maintain assisted primary patency. Although
no significant difference in early failure existed (one-stage, 22.9% vs two-
stage, 9.1%, P  .2), the two-stage BBAVF showed significantly improved
primary patency (hazard ratio, 0.31; 95% CI, 0.09-0.99; P  .048) and
significantly improved secondary patency (hazard ratio, 0.18; 95% CI,
0.04-0.84; P  .03). Mean primary patency for one stage BBAVF was 72.3
weeks and two-stage was 138 weeks (1 SD; P  .05). Mean secondary
patency was 94 weeks and 139 weeks, respectively (1 SD; P .05). Primary
patency at 1 year for one- and two-stage stage BBAVF was 78% and 84%,
respectively (P  .05). Functional primary patency at 1 year for one- and
two-stage BBAVF was 61% and 88%, respectively (P  .05). Complication
rates were not statistically different (each greater than P  .11).
Conclusions: Patency rates appear to be improved with the two-stage
BBAVF. There is no difference in the complication rate. Optimal surgical
techniques for patients undergoing BBAVF for dialysis are discussed. Longer-
lasting hemodialysis access improves patient outcome and decreases morbid-
ity associated with dialysis.
Efficiency of the KDOQI Guidelines for Vascular Access in an Aca-
demic Setting
Traci A. Kimball, MD, Ken Barz, Kelly Dimond, MD, James Edwards, MD,
and Mark R. Nehler, MD, Department of Surgery, University of Colorado
Denver Anschutz Medical Campus, Denver, CO, Denver, CO, and Port-
land, OR
Background: The National Kidney Foundation-Kidney Disease Out-
comes Quality Initiative (KDOQI) for Vascular Access guidelines state that
late-stage chronic kidney disease (CKD) patients should undergo native
arteriovenous fistula (AVF) creation at least 6 months before the anticipated
start of hemodialysis (HD) treatments to obviate the need for other vascular
access types. The objective was to determine the incidence of HD, the
functional patency, and associated morbidity of AVFs in late-stage CKD
patients placed according to KDOQI.
Methods: Consecutive patients with late-stage CKD who underwent
“first-time” index AVF creation using K/DOQI guidelines for anatomy
between January 2003 and December 2007 at three tertiary academic
centers were retrospectively evaluated. Baseline demographics, index AVF
type, and clinical comorbidities were recorded. Patients were stratified into
one of four groups (A-D) over the follow-up course based on the patency of
their index AVF and whether or not they began HD. The ideal primary
outcome was AVF maturation and use for HD (group A; cumulative
functional patency). Other outcomes included AVF patency but no HD
(group B), HD with AVF failure (group C), or no HD and AVF abandon-
ment (group D). Secondary end points were time to first cannulation,
complications, and secondary interventions.
Results: Index AVFs were created (46% forearm and 54% upper arm) in
150 CKD patients (85% male; median age, 63 years). At a median follow-up
of 10 months, 74 patients (49%) were receiving HD and 48 (65%) were
using their index AVF (group A), while 26 (35%) were not (group C).
Thirty-four patients (23%) never initiated HD treatments, but had a viable
AVF. AVF abandonment was 51%. Mean maturation time of all index AVFs
that were cannulated was 285 days (range, 30-1265 days). Complications
encountered were maturation failure for cannulation (15%), focal stenosisrequiring intervention (13%), inadequate flows on HD (9%), steal syndrome
(9%), and thrombosis (8%). Cumulative functional patency for all index
AVFs was 19% at 6 months and 27% at 12 months, with a mean number of
two interventions per AVF (range, 1-10). Mortality for the group during the
study was 23%.
Conclusion: AVF creation in late-stage CKD patients has sobering
results. This calls into question the wisdom of early AVF planning in this
population.
Serum Metalloproteinases MMP-2, MMP-9, and Metalloproteinase
Tissue Inhibitors (TIMP) in Patients Are Associated with Arterio-
venous Fistula Maturation
Eugene S. Lee, MD, Qiang S. Shen, MD, Mingzhang Guo, PhD, Robert L.
Pitts, Mack H. Wu, MD, and Sarah Y. Yuan, MD, Surgery, UC Davis,
Sacramento, CA
Objective: Many vascular surgeons construct arteriovenous fistula
(AVF) for hemodialysis access as the primary choice access. However, a
significant number of AVF fail to mature, leading to patient frustration and
repeated operations. MMP activity, particularly MMP-2 and MMP-9, are
considered important for AVF maturation. We therefore sought to identify
whether serum MMPs could serve as a biomarker for predicting future
successful AVF maturation.
Methods:Blood was collected at the time of surgery from patients with
chronic renal insufficiency requiring long-term access. Serum was separated
from whole blood by the use of an ultracentrifuge at 1000g for 10 minutes.
Serum aliquots were frozen at –80°C until used for analysis. MMP-2,Fig.
